US Patent 10538786 Recombinant arterivirus replicon systems and uses thereof
Patent 10538786 was granted and assigned to Janssen Pharmaceuticals on January, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10538786 Recombinant arterivirus replicon systems and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.